1. Home
  2. ANVS vs KUKE Comparison

ANVS vs KUKE Comparison

Compare ANVS & KUKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • KUKE
  • Stock Information
  • Founded
  • ANVS 2008
  • KUKE 2002
  • Country
  • ANVS United States
  • KUKE China
  • Employees
  • ANVS N/A
  • KUKE N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • KUKE Other Consumer Services
  • Sector
  • ANVS Health Care
  • KUKE Real Estate
  • Exchange
  • ANVS Nasdaq
  • KUKE Nasdaq
  • Market Cap
  • ANVS 110.4M
  • KUKE 49.8M
  • IPO Year
  • ANVS 2020
  • KUKE 2021
  • Fundamental
  • Price
  • ANVS $9.57
  • KUKE $0.90
  • Analyst Decision
  • ANVS Strong Buy
  • KUKE
  • Analyst Count
  • ANVS 6
  • KUKE 0
  • Target Price
  • ANVS $29.67
  • KUKE N/A
  • AVG Volume (30 Days)
  • ANVS 341.4K
  • KUKE 834.1K
  • Earning Date
  • ANVS 11-06-2024
  • KUKE 11-05-2024
  • Dividend Yield
  • ANVS N/A
  • KUKE N/A
  • EPS Growth
  • ANVS N/A
  • KUKE N/A
  • EPS
  • ANVS N/A
  • KUKE N/A
  • Revenue
  • ANVS N/A
  • KUKE $14,784,158.00
  • Revenue This Year
  • ANVS N/A
  • KUKE N/A
  • Revenue Next Year
  • ANVS N/A
  • KUKE N/A
  • P/E Ratio
  • ANVS N/A
  • KUKE N/A
  • Revenue Growth
  • ANVS N/A
  • KUKE N/A
  • 52 Week Low
  • ANVS $4.53
  • KUKE $0.47
  • 52 Week High
  • ANVS $22.49
  • KUKE $4.07
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 58.70
  • KUKE 56.06
  • Support Level
  • ANVS $9.00
  • KUKE $0.47
  • Resistance Level
  • ANVS $10.54
  • KUKE $1.00
  • Average True Range (ATR)
  • ANVS 0.81
  • KUKE 0.16
  • MACD
  • ANVS 0.12
  • KUKE 0.03
  • Stochastic Oscillator
  • ANVS 74.57
  • KUKE 84.92

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

About KUKE Kuke Music Holding Limited

Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.

Share on Social Networks: